Trial Profile
A phase II study of GLS-5700 for Zika-virus infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2017
Price :
$35
*
At a glance
- Drugs GLS 5700 (Primary)
- Indications Zika virus infection
- Focus Therapeutic Use
- 12 Aug 2017 New trial record